ENDRA Life Sciences Inc.
Company Snapshot: ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
- May 25 2022 ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with Issuance of 27th U.S. Patent
- May 16 2022 ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference
- May 12 2022 ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
- May 10 2022 ENDRA Life Sciences Issued Additional U.S. and Chinese Patents for its TAEUS® System